Eli Lilly (LLY) Ending Cash Balance (2009 - 2026)
Eli Lilly's Ending Cash Balance was $4.89 billion in Q3 2026, down 50.1% from $9.79 billion a year earlier and down 45.4% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, Ending Cash Balance at Eli Lilly came in at $7.27 billion, up 122.4% from FY2024.
- Ending Cash Balance has now increased for three consecutive years, with a five-year compound annual growth rate of 14.7% (FY2020 to FY2025).
- In earlier years, Ending Cash Balance was $3.27 billion in FY2024 (+15.9%), $2.82 billion in FY2023 (+36.4%), $2.07 billion in FY2022 (-45.9%) and $3.82 billion in FY2021 (+4.4%).
- The Q3 2026 figure marks the lowest quarterly Ending Cash Balance since Q2 2025.
- Compared with a year earlier, Ending Cash Balance was higher in seven of the last eight quarters, with growth averaging 68.1%.
- The best year-over-year quarter for Ending Cash Balance over five years was Q3 2025 (growth of 190.7%); the worst was Q3 2026 (a decline of 50.1%).
- Per Business Quant data, LLY's Ending Cash Balance in the three quarters before Q3 2026 was $8.95 billion (Q2 2026), $5.28 billion (Q1 2026) and $7.27 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,286.35 Bn | 1,259.96 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 655.58 Bn | 575.44 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 509.44 Bn | 477.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.14 Bn | 325.14 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 309.04 Bn | 282.62 Bn | - | - |
| 6 | Astrazeneca | 289.57 Bn | 263.55 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 248.97 Bn | 200.62 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.95 Bn | 182.98 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 170.25 Bn | 117.91 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Vertex Pharmaceuticals | 137.54 Bn | 109.53 Bn | 2.91 Bn | 4.99 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.89 Bn |
| Jun 30, 2026 | 8.95 Bn |
| Mar 31, 2026 | 5.28 Bn |
| Dec 31, 2025 | 7.27 Bn |
| Sep 30, 2025 | 9.79 Bn |
| Jun 30, 2025 | 3.38 Bn |
| Mar 31, 2025 | 3.09 Bn |
| Dec 31, 2024 | 3.27 Bn |
| Sep 30, 2024 | 3.37 Bn |
| Jun 30, 2024 | 3.22 Bn |
| Mar 31, 2024 | 2.46 Bn |
| Dec 31, 2023 | 2.82 Bn |
| Sep 30, 2023 | 2.38 Bn |
| Jun 30, 2023 | 2.69 Bn |
| Mar 31, 2023 | 3.55 Bn |
| Dec 31, 2022 | 2.07 Bn |
| Sep 30, 2022 | 2.62 Bn |
| Jun 30, 2022 | 2.62 Bn |
| Mar 31, 2022 | 2.46 Bn |
| Dec 31, 2021 | 3.82 Bn |
API Access
Eli Lilly Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();